Valuation: SI-BONE, Inc.

Market Cap 961M 862M 797M 722M 1.35B 91.52B 1.36B 9.53B 3.8B 47.89B 3.61B 3.53B 152B P/E 2026 *
-53.5x
P/E 2027 * -63.5x
Enterprise Value 967M 868M 802M 727M 1.36B 92.13B 1.37B 9.59B 3.82B 48.21B 3.63B 3.55B 153B EV / Sales 2026 *
4.17x
EV / Sales 2027 * 3.58x
Free-Float
96.75%
Yield 2026 *
-
Yield 2027 * -
1 day+1.82%
1 week+6.28%
Current month+16.12%
1 month+17.43%
3 months+28.04%
6 months+66.01%
Current year+10.70%
1 week 20.66
Extreme 20.665
21.96
1 month 17.95
Extreme 17.95
21.96
Current year 11.48
Extreme 11.48
21.96
1 year 11.48
Extreme 11.48
21.96
3 years 11.48
Extreme 11.48
21.96
5 years 11.14
Extreme 11.14
29.51
10 years 7.2
Extreme 7.2
37.21
Manager TitleAgeSince
Chief Executive Officer 59 20/04/2021
Director of Finance/CFO 46 19/04/2021
Chief Tech/Sci/R&D Officer 60 01/12/2024
Director TitleAgeSince
Chairman 71 18/03/2008
Director/Board Member 72 01/01/2013
Director/Board Member 56 18/03/2008
Date Insider Type Main position Quantity % Market Cap. Importance
10/12/26 A Sell

Chief Executive Officer

-38,006 0.0848%
10/5/26 A Sell

Chief Financial Officer

-1,731 0.0039%
10/2/26 A Sell

General Counsel

-3,133 0.0070%
Change 5-day change 1-year change 3-year change Capi.($)
+1.82%+6.28%+39.40%+29.71% 961M
-0.45%+0.19%-19.30%+10.54% 178B
+0.86%-0.13%-20.78%+16.07% 116B
+0.88%+0.16%+0.69%+36.51% 115B
-2.26%+18.07%-43.85%+5.76% 93.1B
-0.31%-5.51%-3.48%+72.86% 62.09B
+0.17%+1.64%+8.50%+82.24% 55.87B
+0.07%+0.70%+4.34%-22.43% 53.12B
+0.30%+0.89%-13.05%+43.83% 44.22B
+0.10%+3.37%-4.73%-8.71% 33.59B
Average +0.43%+2.49%-5.23%+26.64% 75.2B
Weighted average by Cap. +0.12%+2.37%-13.37%+24.04%

Financials

2026 *2027 *
Net sales 232M 208M 193M 174M 326M 22.11B 330M 2.3B 917M 11.57B 871M 853M 36.73B 268M 241M 223M 202M 377M 25.57B 381M 2.66B 1.06B 13.38B 1.01B 986M 42.47B
Net income -17.76M -15.94M -14.73M -13.34M -24.93M -1.69B -25.23M -176M -70.16M -885M -66.65M -65.24M -2.81B -15.42M -13.84M -12.79M -11.59M -21.64M -1.47B -21.91M -153M -60.92M -769M -57.87M -56.65M -2.44B
Net Debt 6.44M 5.77M 5.34M 4.83M 9.03M 613M 9.14M 63.82M 25.42M 321M 24.15M 23.64M 1.02B 715K 641K 593K 537K 1M 68.05M 1.01M 7.09M 2.82M 35.61M 2.68M 2.62M 113M
Projected Income Statement - Annual - SI-BONE, Inc.
Logo SI-BONE, Inc.
SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
Employees
376
Date Price Change Volume
28/10/26 $21.83 +1.82% 452,492
27/10/26 $21.44 +0.61% 482,179
26/10/26 $21.31 -0.79% 361,060
23/10/26 $21.48 -0.37% 469,089
22/10/26 $21.56 +3.55% 527,759
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - SI-BONE, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
21.82USD
Average target price
25.44USD
Spread / Average Target
+16.61%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - SI-BONE, Inc.
  1. Stock Market
  2. Stocks
  3. SIBN Stock